Grifols (GRFS) Other Non Operating Income (2009 - 2018)
Grifols (GRFS) posted Other Non Operating Income of $4.2 million for Q2 2018, down 72.48% quarter-over-quarter from $15.4 million in Q2 2017, and down 72.48% year-on-year from $15.4 million in Q2 2017.
Grifols (GRFS) Other Non Operating Income (2009 - 2018) Analysis & Trends
Grifols (GRFS) has reported Other Non Operating Income for 8 consecutive years, with $4.2 million the latest figure, recorded in Q2 2018.
- Other Non Operating Income for Q2 2018 came in at $4.2 million, down 72.48% year-over-year; the trailing twelve-month figure through Jun 2018 was $27.7 million (down 8.75% YoY), and the FY2025 annual result was -$64.0 million, changed 0.15% from the prior year.
- Other Non Operating Income was $4.2 million for Q2 2018 at Grifols, down from $15.4 million in the prior quarter.
- Over five years, Other Non Operating Income peaked at $15.4 million in Q2 2017 and troughed at -$3.0 million in Q1 2016.
- Average Other Non Operating Income over 4 years is $5.9 million, with a median of $5.6 million recorded in 2016.
- The widest YoY moves for Other Non Operating Income: up 221.3% in 2016, down 129.14% in 2016.
- Over 4 years, Other Non Operating Income stood at $10.5 million in 2015, then tumbled by 33.26% to $7.0 million in 2016, then soared by 120.93% to $15.4 million in 2017, then sank by 72.48% to $4.2 million in 2018.
- Per Business Quant data, the three most recent Other Non Operating Income figures were $4.2 million in Q2 2018, $15.4 million in Q2 2017, and $7.0 million in Q4 2016.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - |
| 10 | Grifols | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 4.24 Mn |
| Jun 30, 2017 | 15.41 Mn |
| Dec 31, 2016 | 6.98 Mn |
| Sep 30, 2016 | 1.06 Mn |
| Jun 30, 2016 | 6.90 Mn |
| Mar 31, 2016 | -2.97 Mn |
| Dec 31, 2015 | -2.97 Mn |
| Sep 30, 2015 | 4.22 Mn |
| Jun 30, 2015 | 2.15 Mn |
| Mar 31, 2015 | 10.20 Mn |
| Dec 31, 2014 | 11.28 Mn |
| Sep 30, 2014 | -25.62 Mn |
| Jun 30, 2014 | -829,982.39 |
| Mar 31, 2014 | 2.02 Mn |
| Dec 31, 2013 | 5.13 Mn |
| Sep 30, 2013 | 5.94 Mn |
| Jun 30, 2013 | 403,477.94 |
| Mar 31, 2013 | -6.46 Mn |
| Dec 31, 2012 | 5.14 Mn |
| Sep 30, 2012 | -67,532.92 |